L. S. van der Schoot

Female patients are less satisfied with biological treatment for psoriasis and experience more side‐effects than male patients: results from the prospective BioCAPTURE registry

L. S. van der Schoot, J.M.P.A. van den Reek, J.M.M. Groenewoud et al. · Journal of the European Academy of Dermatology and Venereology · 2019 · 51 citations

Release of α-glutathione S-transferase (aGST) and π-glutathione S-transferase (πGST) from ischemic damaged kidneys into the machine perfusate—relevance to viability assessment

J.K. Kievit, A. P. Nederstigt, A.P.A. Oomen et al. · Transplantation Proceedings · 1997 · 31 citations

Renal Function, π-Glutathione S-transferase, Kidney Research +9

Dose reduction of the new generation biologics (IL-17 and IL-23 inhibitors) in psoriasis: study protocol for an international, pragmatic, multicenter, randomized, controlled, non-inferiority study—the BeNeBio study

L. S. van der Schoot, J.M.P.A. van den Reek, Lynda Grine et al. · Trials · 2021 · 21 citations · Full text

Attitudes and behaviour regarding dose reduction of biologics for psoriasis: a survey among dermatologists worldwide

M. E. van Muijen, L. S. van der Schoot, J.M.P.A. van den Reek et al. · Archives of Dermatological Research · 2021 · 14 citations · Full text

Evaluation of a One-step Dose Reduction Strategy of Adalimumab, Etanercept and Ustekinumab in Patients with Psoriasis in Daily Practice

Semra Atalay, L. S. van der Schoot, L. M. D. Vandermaesen et al. · Acta Dermato Venereologica · 2021 · 10 citations · Full text

Low Disease Activity, Dose Reduction Strategy, Medicine +10